Unknown

Dataset Information

0

JCAD: a new GWAS target to reduce residual cardiovascular risk?

ABSTRACT:

SUBMITTER: Guzik TJ 

PROVIDER: S-EPMC10200022 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

JCAD: a new GWAS target to reduce residual cardiovascular risk?

Guzik Tomasz J TJ   Channon Keith M KM  

European heart journal 20230501 20

Similar Datasets

Unknown Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
| S-EPMC11873788 | biostudies-literature
Unknown Targeting inflammation to reduce cardiovascular disease risk.
| S-EPMC5659995 | biostudies-literature
Unknown Bibliometric analysis of residual cardiovascular risk: trends and frontiers.
| S-EPMC10683255 | biostudies-literature
Unknown Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk.
| S-EPMC9657259 | biostudies-literature
Unknown Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk.
| S-EPMC3146376 | biostudies-literature
Unknown Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.
| S-EPMC3819768 | biostudies-literature
Unknown Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment.
| S-EPMC4845218 | biostudies-literature
Unknown Integrative Treatments to Reduce Risk for Cardiovascular Disease.
| S-EPMC3065837 | biostudies-literature
Unknown CD47: a new target in cardiovascular therapy.
| S-EPMC2553319 | biostudies-literature
Unknown Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease.
| S-EPMC6727875 | biostudies-literature